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BACKGROUND 
Bioimpedance  spectroscopy  (BIS)  assesses  resistance  (impedance)  to  the  flow  of  an  electrical  current. 
Through the measurement of impedance to currents at low (R0) and high (Rinf) frequencies, extracellular 
fluid  (ECF)  and  total  body  fluid  (TBF)  can  be  measured,  respectively,  and  intracellular  fluid  (Ri  =  ICF) 
subsequently extrapolated (TBW = ECF + ICF).  
Measuring bilateral upper‐limb or lower‐limb secondary lymphoedema following cancer is complicated by 
the  unavailability  of  a  comparable,  unaffected  limb.  Availability  of  normative  BIS  data  for  all  4  limb 
segments would  enable  an  extension  of  BIS  in  the  diagnosis  of  bilateral  upper‐,  as well  as  lower‐limb 
lymphoedema.  







































































































 Total Dataset A Dataset B Dataset C Dataset D Dataset E 
N 909 33 489 63 89 235 
 Mean (SD) 
Range 
Age (y) 48 (15) 38 (12) 42 (15) 55 (11) 54 (13) 58 (7) 
 18, 87 21, 60 18, 87 40, 82 24, 83 44, 69 
BMI (kg/m2) 25.7 (4.4) 25.1 (5.1) 25.8 (4.4) 27.5 (5.6) 26.7 (4.3) 24.5 (3.6) 
 16.1, 46 17.9, 41.1 16.1, 46 16.4, 42.7 18.6, 38.5 17.2, 37.4 
Number of times BIS measured 2 (2) 12 (6) 1 (0) 1 (0) 2 (1) 1 (0) 
 1, 23 5, 23 1, 1 1, 1 1, 3 1, 1 
 N (%) 
Female 596 (66) 22 (67) 273 (56) 63 (100) 89 (100) 149 (63) 
Right side dominant  853 (94) 31 (94) 465 (95) 55 (87) 81 (91) 221 (94) 
BMI categories (kg/m2)       
    Underweight (<18.5) 68 (7) 6 (18) 37 (8) 6 (10) 4 (4) 15 (6) 
    Healthy weight (18.5-24.9) 377 (41) 11 (33) 191 (39) 15 (24) 33 (37) 127 (54) 
    Overweight (25.0-29.9) 322 (35) 13 (39) 179 (37) 25 (40) 32 (36) 73 (31) 
    Obese (30.0+) 142 (16) 3 (9) 82 (17) 17 (27) 20 (22) 20 (9) 
   
































N Mean SD -0.5SD +0.5SD -0.75SD +0.75SD -1SD +1SD -1.5SD +1.5SD -2SD +2SD -2.5SD +2.5SD -3SD +3SD 
899 1.132 0.176 1.044 1.220 1.000 1.264 0.955 1.308 0.868 1.396 0.780 1.485 0.692 1.573 0.603 1.659 
 
TABLE 3. Normative arm to leg ratios of R0 – non‐dominant side 
N Mean SD -0.5SD +0.5SD -0.75SD +0.75SD -1SD +1SD -1.5SD +1.5SD -2SD +2SD -2.5SD +2.5SD -3SD +3SD 
722 1.167 0.173 1.080 1.253 1.037 1.296 0.994 1.340 0.908 1.426 0.822 1.512 0.736 1.598 0.649 1.685 
 
TABLE 4. Normative arm to leg ratios of Ri:R0 – dominant side 
N Mean SD -0.5SD +0.5SD -0.75SD +0.75SD -1SD +1SD -1.5SD +1.5SD -2SD +2SD -2.5SD +2.5SD -3SD +3SD 
896 1.197 0.452 0.971 1.422 0.858 1.535 0.745 1.649 0.519 1.875 0.293 2.100 0.067 2.327 -0.158 2.551 
 
TABLE 5. Normative arm to leg ratios of Ri:R0 – non‐dominant side 
N Mean SD -0.5SD +0.5SD -0.75SD +0.75SD -1SD +1SD -1.5SD +1.5SD -2SD +2SD -2.5SD +2.5SD -3SD +3SD 
720 1.127 0.371 0.942 1.312 0.849 1.405 0.755 1.498 0.570 1.683 0.385 1.868 0.199 2.054 0.013 2.241 
 
TABLE 6. Normative arm to arm ratios of R0 – dominant over non‐dominant 
N Mean SD -0.5SD +0.5SD -0.75SD +0.75SD -1SD +1SD -1.5SD +1.5SD -2SD +2SD -2.5SD +2.5SD -3SD +3SD 
717 0.987 0.068 0.953 1.021 0.936 1.038 0.919 1.055 0.885 1.089 0.851 1.123 0.817 1.157 0.783 1.191 
 
TABLE 7. Normative leg to leg ratios of R0 – dominant over non‐dominant 
N Mean SD -0.5SD +0.5SD -0.75SD +0.75SD -1SD +1SD -1.5SD +1.5SD -2SD +2SD -2.5SD +2.5SD -3SD +3SD 
716 1.004 0.071 0.968 1.039 0.951 1.057 0.933 1.075 0.897 1.111 0.862 1.146 0.826 1.182 0.791 1.218 
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TABLE 8. Characteristics of subjects with clinically diagnosed lymphoedema 
 Total Upper-limb Lower-limb 
N 28 20 8 
 Mean (SD) 
Range
Age (y) 61 (11) 59 (12) 63 (7) 
 37-77 37-77 51-76 
BMI (kg/m2) 29.0 (5.9) 30.0 (5.9) 26.3 (5.1) 
 19.9-41.9 19.9-41.9 19.9-33.5 
 N (%)
Female 26 (93) 19 (95) 7 (88) 
Right side Dominant  27 (96) 19 (95) 8 (100) 
BMI categories (kg/m2)    
    Underweight (<18.5) - - - 
    Healthy weight (18.5-24.9) 8 (29) 5 (25) 3 (38) 
    Overweight (25.0-29.9) 8 (29) 5 (25) 3 (38) 
    Obese (30.0+) 11 (39) 10 (50) 1 (13) 
    Unknown 1 (4) - 1 (13) 
 Median (IQR) 
Range
Duration of lymphoedema (years) 4 (1-8) 4 (1-7) 7 (4-9) 
 0.1-34 0.1-34 1-21 
 N (%)
Lymphoedema secondary to    
    Breast cancer 18 (64) 18 (90) - 
    Cervical cancer 2 (7) - 2 (25) 
    Endometrial cancer 1 (4) - 1 (13) 
    Melanoma 3 (11) 1 (5) 2 (25) 
    Uterine cancer 3 (11) - 3 (38) 
    Unknown 1 (4) 1 (5) - 
Side of lymphoedema    
    Dominant only 13 (46) 12 (60) 1 (12) 
    Non-dominant only 7 (25) 7 (35) - 
    Bilateral 8 (29) 1 (5) 7 (88) 
Stage    
    I 8 (29) 6 (30) 2 (25) 
    II 16 (57) 12 (60) 4 (50) 
    III 4 (14) 2 (10) 2 (25) 
    IV - - - 
Pitting 18 (64) 13 (65) 5 (63) 
Non-pitting 3 (11) 3 (15) - 
Pitting and non-pitting 7 (25) 4 (20) 3 (38) 
Thickening 19 (68) 14 (70) 5 (63) 
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Lower-limb Dominant Non-dominant 




































*Two sample t-tests were used to compare mean limb ratios between the lymphoedema and normative datasets. 
  

































Cut-off criterion Dominant side cut-off 
Non-dominant 
side cut-off Sensitivity (95% CI) Specificity (95% CI) AUC (95% CI) 
Arm R0 / leg R0  
    
Mean - 0.5 SD <1.044 <1.081 0.75 (0.51-0.91) 0.75 (0.35-0.97) 0.75 (0.56-0.94)
Mean - 0.75 SD <1.000 <1.037 0.55 (0.32-0.77) 1.00 (0.52-1.00) 0.78 (0.66-0.89)
Mean - 1.0 SD <0.956 <0.994 0.45 (0.23-0.68) 1.00 (0.52-1.00) 0.72 (0.61-0.84)
Mean - 1.5 SD <0.868 <0.908 0.35 (0.15-0.59) 1.00 (0.52-1.00) 0.68 (0.57-0.78)
Mean - 2.0 SD <0.780 <0.822 0.10 (0.01-0.32) 1.00 (0.52-1.00) 0.55 (0.48-0.62)
Mean - 2.5 SD <0.692 <0.735 0.00 (0.00-0.24) 1.00 (0.52-1.00) 0.50 (0.50-0.50)
Mean - 3.0 SD <0.603 <0.649 0.00 (0.00-0.24) 1.00 (0.52-1.00) 0.50 (0.50-0.50)
Arm Ri:R0 / leg Ri:R0  
    
Mean - 0.5 SD <0.971 <0.942 0.45 (0.23-0.68) 0.12 (0.00-0.53) 0.36 (0.28-0.44)
Mean - 0.75 SD <0.858 <0.849 0.30 (0.12-0.54) 0.12 (0.00-0.53) 0.40 (0.32-0.48)
Mean - 1.0 SD <0.745 <0.755 0.10 (0.01-0.32) 0.50 (0.16-0.84) 0.35 (0.25-0.45)
Mean - 1.5 SD <0.519 <0.570 0.00 (0.00-0.24) 0.88 (0.47-1.00) 0.44 (0.32-0.56)
Mean - 2.0 SD <0.293 <0.385 0.00 (0.00-0.24) 1.00 (0.52-1.00) 0.50 (0.50-0.50)
Mean - 2.5 SD <0.067 <0.199 0.00 (0.00-0.24) 1.00 (0.52-1.00) 0.50 (0.50-0.50)
Mean - 3.0 SD <-0.158 <0.013 0.00 (0.00-0.24) 1.00 (0.52-1.00) 0.50 (0.50-0.50)
Arm R0 / arm R0  
    
Mean  0.5 SD <0.953 >1.021 1.00 (0.76-1.00) 0.50 (0.16-0.84) 0.75 (0.56-0.94)
Mean +/- 0.75 SD <0.936 >1.038 1.00 (0.76-1.00) 0.62 (0.24-0.91) 0.81 (0.63-0.99)
Mean +/- 1.0 SD <0.919 >1.055 0.95 (0.75-1.00) 0.75 (0.35-0.97) 0.85 (0.68-1.00)
Mean +/- 1.5 SD <0.885 >1.089 0.90 (0.68-0.99) 1.00 (0.52-1.00) 0.95 (0.88-1.00)
Mean +/- 2.0 SD <0.851 >1.123 0.70 (0.46-0.88) 1.00 (0.52-1.00) 0.85 (0.75-0.95)
Mean +/- 2.5 SD <0.817 >1.157 0.50 (0.27-0.73) 1.00 (0.52-1.00) 0.75 (0.64-0.86)









Cut-off criterion Dominant side cut-off 
Non-dominant 
side cut-off Sensitivity (95% CI) Specificity (95% CI) AUC (95% CI) 
Arm R0 / leg R0  
    
Mean + 0.5 SD >1.220 >1.254 0.75 (0.35-0.97) 0.60 (0.36-0.81) 0.68 (0.48-0.87)
Mean + 0.75 SD >1.264 >1.297 0.75 (0.35-0.97) 0.80 (0.56-0.94) 0.78 (0.59-0.96)
Mean + 1.0 SD >1.308 >1.340 0.75 (0.35-0.97) 0.85 (0.62-0.97) 0.80 (0.62-0.98)
Mean + 1.5 SD >1.396 >1.427 0.62 (0.24-0.91) 0.90 (0.68-0.99) 0.76 (0.57-0.95)
Mean + 2.0 SD >1.484 >1.512 0.50 (0.16-0.84) 1.00 (0.76-1.00) 0.75 (0.56-0.94)
Mean + 2.5 SD >1.572 >1.598 0.50 (0.16-0.84) 1.00 (0.76-1.00) 0.75 (0.56-0.94)
Mean + 3.0 SD >1.661 >1.685 0.25 (0.03-0.65) 1.00 (0.76-1.00) 0.62 (0.46-0.79)
Arm Ri:R0 / leg Ri:R0  
    
Mean + 0.5 SD >0.971 >1.312 0.00 (0.00-0.48) 0.80 (0.56-0.94) 0.40 (0.31-0.49)
Mean + 0.75 SD >1.535 >1.405 0.00 (0.00-0.48) 0.90 (0.68-0.99) 0.45 (0.38-0.52)
Mean + 1.0 SD >1.649 >1.498 0.00 (0.00-0.48) 0.95 (0.75-1.00) 0.48 (0.43-0.52)
Mean + 1.5 SD >1.875 >1.683 0.00 (0.00-0.48) 0.95 (0.75-1.00) 0.48 (0.43-0.52)
Mean + 2.0 SD >2.100 >1.868 0.00 (0.00-0.48) 1.00 (0.76-1.00) 0.50 (0.50-0.50)
Mean + 2.5 SD >2.327 >2.054 0.00 (0.00-0.48) 1.00 (0.76-1.00) 0.50 (0.50-0.50)
Mean + 3.0 SD >2.551 >2.241 0.00 (0.00-0.48) 1.00 (0.76-1.00) 0.50 (0.50-0.50)
Leg R0 / leg R0  
    
Mean ± 0.5 SD <0.969 >1.040 0.75 (0.35-0.97) 0.50 (0.27-0.73) 0.62 (0.43-0.82)
Mean ± 0.75 SD <0.951 >1.057 0.62 (0.24-0.91) 0.70 (0.46-0.88) 0.66 (0.46-0.87)
Mean ± 1.0 SD <0.933 >1.075 0.62 (0.24-0.91) 0.80 (0.56-0.94) 0.71 (0.51-0.91)
Mean ± 1.5 SD <0.898 >1.111 0.50 (0.16-0.84) 0.95 (0.75-1.00) 0.72 (0.53-0.92)
Mean ± 2.0 SD <0.862 >1.146 0.50 (0.16-0.84) 0.95 (0.75-1.00) 0.72 (0.53-0.92)
Mean ± 2.5 SD <0.826 >1.182 0.50 (0.16-0.84) 0.95 (0.75-1.00) 0.72 (0.53-0.92)






17 | P a g e  
 
 
REFERENCES 
1.	 Hayes,	S.,	D.	Battistutta,	and	B.	Newman,	Objective	and	subjective	upper	body	
function	six	months	following	diagnosis	of	breast	cancer.	Breast	cancer	research	
and	treatment,	2005.	94(1):	p.	1‐10.	
2.	 Hayes,	S.,	B.	Cornish,	and	B.	Newman,	Comparison	of	methods	to	diagnose	
lymphoedema	among	breast	cancer	survivors:	6‐month	follow‐up.	Breast	cancer	
research	and	treatment,	2005.	89(3):	p.	221‐6.	
3.	 Ward,	L.C.,	Inter‐instrument	comparison	of	bioimpedance	spectroscopic	analysers.	
The	Open	Medical	Devices	Journal,	2009.	1:	p.	3‐10.	
4.	 Cornish,	B.H.,	et	al.,	Optimizing	electrode	sites	for	segmental	bioimpedance	
measurements.	Physiological	measurement,	1999.	20(3):	p.	241‐50.	
5.	 Stevenson,	M.,	et	al.,	epiR:	An	R	package	for	the	analysis	of	epidemiological	data	
2015.	
 
